Innospark Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Innospark Ventures/Activity

Innospark Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Participated in Antiverse's $9.3M Series A to expand its AI antibody design platform.

Antiverse

Antiverse Innospark Ventures

linkedin.comMAR 3, 2026

biospace.com

MAR 3, 2026

4 essays· DEC 2024 – OCT 2025Show all

Essay

Investment in Juniper Genomics, applying whole genome sequencing and AI to improve embryo selection and IVF outcomes.

Juniper Genomics

Juniper GenomicsInnospark Ventures

innospark.vcOCT 2025

OCT 2025

Essay

Investment in Krevera, deploying AI-powered computer vision for real-time quality control and process optimization in manufacturing.

Krevera

Krevera Innospark Ventures

innospark.vcJUL 2025

JUL 2025

Essay

Investment in Copernic Catalysts, using computational AI to accelerate discovery of novel catalysts for ammonia synthesis and chemical manufacturing.

Copernic Catalysts

Copernic Catalysts Innospark Ventures

innospark.vcMAR 2025

MAR 2025

Essay

Investment in Phaseshift Technologies, applying advanced AI and computational methods to accelerate design and discovery of next-generation alloys and composites.

Phaseshift Technologies

Phaseshift TechnologiesInnospark Ventures

innospark.vcDEC 2024

DEC 2024